Y-Biologics Participates in 'BIO-Europe 2026' to Expand Global Partnerships
Y-Biologics is participating in 'BIO-Europe 2026' to expand global partnerships.
According to Y-Biologics on the 5th, BIO-Europe is a major partnering event where key stakeholders in the biotechnology industry, including global pharmaceutical companies, biotech firms and investment institutions, gather to showcase drug development technologies and explore strategic cooperation, such as technology transfers and joint research.
At the event, Y-Biologics will hold partnering meetings with global companies, highlighting the latest research results from its immuno-oncology pipeline based on its MultiAppCytokine platform, a multispecific antibody-cytokine fusion platform.
The company plans to use as key partnering materials the latest preclinical research data on its core MultiAppCytokine pipelines, 'AR170 (PD-1×VEGF×IL-2v)' and 'AR166 (PD-1×LAG-3×IL-2v)', which will be presented at the Society for Immunotherapy of Cancer (SITC 2026).
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A Y-Biologics representative said, "We will continue to share our research and development results at major global academic conferences and partnering events, and broaden the foundation for cooperation with global pharmaceutical and biotech companies."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
